Do we need to adopt antifungal stewardship programmes

This journal article concludes that the presence of a multidisciplinary team, including an infection control specialist and a clinical pharmacist, would limit the prescription of advanced antifungal agents as empirical therapy. The authors state that this team would control the de-escalation process —where applicable—leading to a reduction in costs and, probably, a decrease in the emergence of resistant Candida species. These facts contribute to the broader discussion on the adoption of antifungal stewardship programmes.

Source: Current Awareness Service for Health (CASH) - July 4, 2018 Category: Consumer Health News Source Type: news